Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06180733
Status:
RECRUITING
Last Update Posted:
2023-12-22
First Post:
2023-12-04
Brief Title:
Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Organization Data
Organization:
University Medical Center Groningen
Class:
OTHER
Study ID:
PAM-UMCG-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Medical Center Groningen
Lead Sponsor Class:
OTHER
Responsible Party:
Hans W Nijman MD PHD
Responsible Party Title:
Head of Obstetrics and Gynecology Prinicpal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University Medical Center Groningen
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |